title: Missense mutations in exon 5 of the human lipoprotein lipase gene. Inactivation correlates with loss of dimerization.
abstract: Most missense mutations of the lipoprotein lipase (LPL) gene identified among LPL-deficient subjects cluster in a segment of the sequence that encodes the catalytic triad as well as functional elements involved in the activation of the lipase at lipid-water interfaces. Consequently, loss of activity may result either from direct alterations of such functional elements or from less specific effects on protein folding and stability. This issue was addressed by examining biochemical properties of four such variants (A176T, G188E, G195E, and S244T) in a heterologous expression system (COS-1 cells). Variant G195E (GGA----GAA) was previously unreported. In all instances, inactive enzyme was recovered in medium, albeit at reduced levels. Cellular synthesis and extracellular degradation were similar to those for wild type, suggesting that reduced secretion resulted from increased intracellular degradation. When cell extracts were subjected to heparin-Superose affinity chromatography followed by elution on a linear salt gradient, all variants exhibited a single, inactive, low affinity immunoreactive peak. By contrast, wild-type enzyme presented an additional, high affinity, active species, which we interpret as homodimeric enzyme. Substitution of the active-site serine (S132A) led to loss of activity but maintenance of the high affinity species. When large amounts of the G188E variant were applied to the column, small but significant amounts of high affinity, active enzyme were recovered. Systematic substitutions at residue 188 showed that only glycine could accommodate structural constraints at this position. We conclude that the mutations examined did not impart lipase deficiency by affecting specific functional elements of the enzyme. Rather, they appear to affect protein folding and stability, and thereby formation and maintenance of subunit assembly.
authors.affiliation: Howard Hughes Medical Institute, Salt Lake City, Utah.
authors.forename: A
authors.initials: A
authors.lastname: Hata
authors.forename: D N
authors.initials: DN
authors.lastname: Ridinger
authors.forename: S D
authors.initials: SD
authors.lastname: Sutherland
authors.forename: M
authors.initials: M
authors.lastname: Emi
authors.forename: L K
authors.initials: LK
authors.lastname: Kwong
authors.forename: J
authors.initials: J
authors.lastname: Shuhua
authors.forename: A
authors.initials: A
authors.lastname: Lubbers
authors.forename: B
authors.initials: B
authors.lastname: Guy-Grand
authors.forename: A
authors.initials: A
authors.lastname: Basdevant
authors.forename: P H
authors.initials: PH
authors.lastname: Iverius
mesh_terms: D000328:Adult; D000595:Amino Acid Sequence; D001483:Base Sequence; D002478:Cells, Cultured; D002846:Chromatography, Affinity; D004247:DNA / Q000235:genetics; D005091:Exons; D006801:Humans; D008071:Lipoprotein Lipase / Q000037:antagonists & inhibitors / Q000235:genetics* / Q000378:metabolism; D008297:Male; D008969:Molecular Sequence Data; D016297:Mutagenesis, Site-Directed; D009154:Mutation; D009693:Nucleic Acid Hybridization; D011233:Precipitin Tests; D017510:Protein Folding; D014162:Transfection
chemical_list: D004247:DNA; D008071:Lipoprotein Lipase